Aegle’s capital raise will fund the first clinical trial in the U.S. using exosomes isolated from allogeneic mesenchymal stem cells as therapy. Aegle Therapeutics Corp., a first in class biotechnology company isolating extracellular vesicles, including exosomes (“EVs”), secreted by mesenchymal ...
Read More »Addario and Biocept Announce Collaborate on Liquid Biopsy Clinical Trial in Lung Cancer
The Addario Lung Cancer Medical Institute (ALCMI), a non-profit, patient-centric, international research organization, and Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announce a clinical collaboration ...
Read More »Inivata Launches US Clinical Trial of Innovative ctDNA Liquid Biopsy Analysis in Lung Cancer
Inivata, a global clinical cancer genomics company employing a revolutionary approach to circulating tumor DNA (ctDNA) analysis to improve personalized healthcare in oncology, today announces the launch of its US clinical validation study (INI-001) in non-small cell lung cancer (NSCLC). ...
Read More »MolecuVax to Initiate Cancer Immunotherapy Clinical Trial of their Exosome-based Technology
OCEANSIDE, CA–(Marketwired – April 11, 2016) – Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an agreement between its subsidiary, MolecuVax, Inc., (MVAX) and the Pan Am Cancer Treatment Center covering production and clinical implementation of ...
Read More »Upcoming Clinical Trial – Effect of Plasma Derived Exosomes on Cutaneous Wound Healing
ClinicalTrials.gov Identifier: NCT02565264 Sponsor: Kumamoto University Purpose This study is an open prospective clinical trial. The objective is to evaluate the effect of autologous exosomes rich plasma on cutaneous wound healing. The participants are patients with intractable cutaneous ulcers (e.g. ...
Read More »